Kelyniam Global, Inc. (KLYG)
OTCMKTS · Delayed Price · Currency is USD
0.1370
+0.0220 (19.13%)
At close: Dec 30, 2025
Kelyniam Global Market Cap
Kelyniam Global has a market cap or net worth of $6.83 million as of December 30, 2025. Its market cap has increased by 317.47% in one year.
Market Cap
6.83M
Enterprise Value
n/a
Revenue
2.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since April 3, 2008, Kelyniam Global's market cap has increased from 5.24M to 6.83M, an increase of 30.24%. That is a compound annual growth rate of 1.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 5.73M | -26.57% |
| Dec 31, 2024 | 7.80M | 327.63% |
| Dec 28, 2023 | 1.83M | -24.53% |
| Dec 27, 2022 | 2.42M | -4.56% |
| Dec 31, 2021 | 2.53M | -37.32% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 748.72M |
| Elite Pharmaceuticals | 537.07M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 379.67M |
| CytoDyn | 353.44M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 291.10M |